<ѻý class="article_title">
Predicting Outcomes in Graves’ Orbitopathy
ѻý>
Researchers in Korea recently identified predictive factors for normalization of thyroid-stimulating immunoglobulin levels in moderate-to-severe Graves’ orbitopathy, highlighting the importance of early treatment.
<ѻý class="article_title">
In Thyroid-Associated Orbitopathy, Using Smartphones to Assess Disease Activity
ѻý>
A smartphone-based machine learning-assisted system for evaluating clinical activity in thyroid-associated orbitopathy may represent a promising new approach to the diagnosis and management of this condition.
<ѻý class="article_title">
Asymmetry in Thyroid Eye Disease: Prevalence and Characteristics
ѻý>
Asymmetric disease may occur in one-third of patients with thyroid eye disease, with muscle volume expansion possibly contributing to the asymmetry. A standardized definition of asymmetry using more objective parameters is needed to facilitate comparisons among studies.
<ѻý class="article_title">
Thyroid Eye Disease: Is There a Biomarker for Muscle Enlargement?
ѻý>
Investigators retrospectively reviewed medical records of patients with thyroid eye disease to determine the most useful biomarker for extraocular muscle enlargement.
<ѻý class="article_title">
Graves’ Orbitopathy in Thyroid Cancer: Beware Higher Doses of Radioactive Iodine
ѻý>
A South Korean study followed patients with thyroid cancer to assess for risk of Graves’ orbitopathy, finding an association with radioactive iodine treatment.
<ѻý class="article_title">
In Thyroid Eye Disease, Could This Be a Novel Target?
ѻý>
According to a study from Mayo Clinic, pregnancy-associated plasma protein A has a role in the pathogenesis of thyroid eye disease and may be a more selective target for novel therapies modulating insulin-like growth factor activity, the main driver of TED.